Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: J Thorac Oncol. 2015 May;10(5):806–814. doi: 10.1097/JTO.0000000000000486

Figure 3. Cumulative incidence of recurrence (CIR) by spread through air spaces (STAS) in the limited resection group.

Figure 3

(A) CIR for any recurrence of patients with STAS-positive tumors was significantly higher than for patients with STAS-negative tumors (5-year CIR, 42.6% vs. 10.9%; P<0.001). (B) CIR for distant recurrence of patients with STAS-positive tumors was significantly higher than for patients with STAS-negative tumors (5-year CIR, 20.4% vs. 6.8%; P=0.035). (C) CIR for locoregional recurrence of patients with STAS-positive tumors was significantly higher than for patients with STAS-negative tumors (5-year CIR, 22.2% vs. 4.1%; P=0.001).